---
$id: https://graph.org.ai/products/commodity/51111657
$type: Product
source: UNSPSC
code: "51111657"
title: "Tezacitabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tezacitabine

**UNSPSC Code**: 51111657
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a ribonucleotide reductase inhibitor and pyrimidine antagonist with the molecular formula C10H12FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7607Y95N9S, chemically known as mdl 101,731 but generally known as tezacitabine, which bears US NIH Compound Identifier 6435808. The term TEZACITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations schedule tezacitabine under HS 29349990 and SITC 51579. As of Q4 2014, TEZACITABINE remains the US FDA Preferred Term for this commodity. Tezacitabine bears US NLM identifiers UMLS ID C0253087 and NCI Concept Code C1539. SMILES: C1=CN(C(=O)N=C1N)C2C(=CF)C(C(O2)CO)O.

